JPH03382B2 - - Google Patents

Info

Publication number
JPH03382B2
JPH03382B2 JP13184882A JP13184882A JPH03382B2 JP H03382 B2 JPH03382 B2 JP H03382B2 JP 13184882 A JP13184882 A JP 13184882A JP 13184882 A JP13184882 A JP 13184882A JP H03382 B2 JPH03382 B2 JP H03382B2
Authority
JP
Japan
Prior art keywords
thiourea
reaction
formula
trifluoromethylpropanal
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP13184882A
Other languages
Japanese (ja)
Other versions
JPS5921663A (en
Inventor
Satoru Yoshizawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JNC Corp
Original Assignee
Chisso Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisso Corp filed Critical Chisso Corp
Priority to JP13184882A priority Critical patent/JPS5921663A/en
Publication of JPS5921663A publication Critical patent/JPS5921663A/en
Publication of JPH03382B2 publication Critical patent/JPH03382B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明はチオ尿素誘導体に関する。さらに詳し
くは、チオ尿素とトリフルオロメチルプロパナー
ルの縮合体に関する。 チオ尿素と種々の脂肪族アルデヒドの縮合体お
よびその製造法に関しては従来より数多く知られ
ているが、トリフルオロメチルプロパナールとの
縮合体は知られていない。 本発明者は、脂肪族アルデヒドではあるが、ふ
つ素をその構造中に有するトリフルオロメチルプ
ロパナールに注目し、チオ尿素との反応を試みた
結果、興味深い縮合体を得ることができ、本発明
に到達した。 即ち、本発明はチオ尿素とトリフルオロメチル
プロパナールの縮合体に関するものであり、それ
は次の一般式(1)で表わす反応で得ることができ
る。 H2N−CS−NH2+CH3CH(CF3)CHO→R1
NH−CS−NH−R2 (1) () ここに縮合体()においてR1−はCH3C
(CF3)=CH−またはCH3CH(CF3)−CH(NH−
CS−NH2)−を示し、またR2−はH−、CH3C
(CF3)=CH−またはCH3CH(CF3)−CH(NH−
CS−NH2)−を示す。 本発明における縮合反応(1)は通常、溶媒中で行
うのが好適であり溶媒としてはトルエン、ジオキ
サン、テトラヒドロフラン、エーテル、DMF、
ベンゼン、アセトニトリル、クロロホルム、1,
2−ジクロルエタン、酢酸エチル、アセトン等が
適当である。 本発明における反応(1)の温度は室温ないし、用
いる溶媒の沸点までの範囲内で可能である。 本発明の反応(1)において用いるチオ尿素とトリ
フルオロメチルプロパナールの割合はモル比で3
対1ないし1対3が適当である。 本発明の反応(1)においては特に触媒を必要とせ
ず、室温ないし溶媒の沸点において数時間ないし
数10時間攪拌するだけで反応を進行させることが
できる。但し縮合反応であるため脱水剤を用いる
と反応を生成物側に有利に導くことができる。脱
水剤としては硫酸ナトリウム、硫酸マグネシウム
またはモレキユラーシーブス等が適している。 本発明の原料の1つであるトリフルオロメチル
プロパナールは例えば3,3,3−トリフルオロ
プロペンをオキソ反応に附することにより高収率
で得られる化合物である。 本発明において得られるふつ素を含んだチオ尿
素誘導体は文献未載の新規物質であつて、抗菌作
用を示し、医薬、濃薬の中間原料として有用な物
質である。 実施例 1 チオ尿素7.6g(0.1mol)をジオキサン20mlに
分散し、トリフルオロメチルプロパナール12.6g
(0.1mol)を加えて10時間還流した。反応後、溶
媒を留去し酢酸エチル20mlを加えて不溶分を除い
た後、シリカゲル−クロロホルム−酢酸エチル系
にてカラムクロマトグラフイーを行い、主な成分
A0.8g、B5.5g、C3.6gの3種を得た。 成分Aはトルエンより再結晶することにより無
色の結晶となり、N,N′−ビス〔(2−トリフル
オロメチル)−プロペニル〕チオ尿素()であ
つた。 〔CH3(CF3)=CH−NH〕−2C=S () Mp:166−7〔℃〕(dec); IRmax(KBrdisk):3450,3290,3225,3130,
3070,1694,1540,1380,1340,1300,1255,
1160,1105,1080,987,900,888,798,760,
715,690,600〔cm-11 H−NMR(Acetone−d6、TMS):δ1.83(S,
6H,C 3)、7.92(d,2H,J=10 Hz,=C
−)、9.23(d,2H,J=10Hz,−N−)〔ppm〕 元素分析:C 37.18、H 3.31、N 9.73〔%〕 同計算値(C9F6H10N2Sとして):C 36.99,H
3.45,N 9.59〔%〕 Mass:m/e、292(m+)、293(m++1);計算
値292(m) 一方成分Bはトルエンより再結晶することによ
り無色の針状晶となり、N−(2−トリフルオロ
メチル)−プロペニルチオ尿素()であつた。 CH3C(CF3)=CH−NH−CS−NH2 () Mp:140−1℃(dec.) IRmax(KBr disk):3520,3385,3220,3190,
3100,1698,1612,1555,1360,1340,1297,
1240,1152,1110,910,800,750,696,667,
600〔cm-11 H−NMR(Acetone−d6,TMS):δ 1.82(S,
3H,C 3)、7.90(d,1H,J=10Hz,=C
NH−)、7.38(bs,2H,−N 2)、8.98(d,1H,
J=10Hz,CH−N−)〔ppm〕 元素分析:C 32.98、H 3.69、N 15.36〔%〕 同計算値〔C5F3H7N2Sとして〕:C 32.61、H
3.83、N 15,21〔%〕 Mass:m/e、184(m+);計算値184(m) また、成分Cはエーテルに溶解し、ヘキサンで
結晶化させることにより黄色の結晶となりN,
N′−ビス〔(1−チオウレイド−2−トリフルオ
ロメチル)−プロピル〕チオ尿素()であつた。 Mp:120−40〔℃〕(dec) IRmax(KBrdisk):3300,3200,1610,1515,
1415,1350,1260,1180,1150,1120,795,745
〔cm-11 H−NMR(Acetone−d6、TMS):1.27(d,
6H,J=7Hz,C 3)、2.9−3.7(broad m,
2H,
The present invention relates to thiourea derivatives. More specifically, it relates to a condensate of thiourea and trifluoromethylpropanal. Although many condensates of thiourea and various aliphatic aldehydes and their production methods have been known, condensates of trifluoromethylpropanal have not been known. The present inventor focused on trifluoromethylpropanal, which is an aliphatic aldehyde but has fluorine in its structure, and attempted to react with thiourea, and as a result, was able to obtain an interesting condensate. reached. That is, the present invention relates to a condensate of thiourea and trifluoromethylpropanal, which can be obtained by the reaction represented by the following general formula (1). H 2 N−CS−NH 2 +CH 3 CH(CF 3 )CHO→R 1
NH−CS−NH−R 2 (1) () Here, in the condensate (), R 1 − is CH 3 C
(CF 3 )=CH− or CH 3 CH(CF 3 )−CH(NH−
CS-NH 2 )-, and R 2 - is H-, CH 3 C
(CF 3 )=CH− or CH 3 CH(CF 3 )−CH(NH−
CS−NH 2 )− is shown. The condensation reaction (1) in the present invention is usually preferably carried out in a solvent, and examples of the solvent include toluene, dioxane, tetrahydrofuran, ether, DMF,
Benzene, acetonitrile, chloroform, 1,
2-dichloroethane, ethyl acetate, acetone, etc. are suitable. The temperature of reaction (1) in the present invention can range from room temperature to the boiling point of the solvent used. The molar ratio of thiourea and trifluoromethylpropanal used in reaction (1) of the present invention is 3.
A ratio of 1:1 to 1:3 is appropriate. Reaction (1) of the present invention does not particularly require a catalyst, and the reaction can proceed simply by stirring for several hours to several tens of hours at room temperature to the boiling point of the solvent. However, since this is a condensation reaction, using a dehydrating agent can advantageously direct the reaction toward the product side. Suitable dehydrating agents include sodium sulfate, magnesium sulfate, and molecular sieves. Trifluoromethylpropanal, which is one of the raw materials of the present invention, is a compound obtained in high yield by subjecting 3,3,3-trifluoropropene to an oxo reaction. The fluorine-containing thiourea derivative obtained in the present invention is a new substance that has not been described in any literature, exhibits antibacterial activity, and is a useful substance as an intermediate raw material for pharmaceuticals and concentrated drugs. Example 1 7.6 g (0.1 mol) of thiourea was dispersed in 20 ml of dioxane, and 12.6 g of trifluoromethylpropanal was added.
(0.1 mol) was added and refluxed for 10 hours. After the reaction, the solvent was distilled off and 20 ml of ethyl acetate was added to remove insoluble matter, followed by column chromatography using a silica gel-chloroform-ethyl acetate system to separate the main components.
Three types were obtained: 0.8 g of A, 5.5 g of B, and 3.6 g of C. Component A became colorless crystals by recrystallization from toluene, and was N,N'-bis[(2-trifluoromethyl)-propenyl]thiourea (). [CH 3 (CF 3 )=CH−NH] − 2 C=S () Mp: 166−7 [℃] (dec); IRmax (KBrdisk): 3450, 3290, 3225, 3130,
3070, 1694, 1540, 1380, 1340, 1300, 1255,
1160, 1105, 1080, 987, 900, 888, 798, 760,
715, 690, 600 [cm -1 ] 1 H-NMR (Acetone-d 6 , TMS): δ1.83 (S,
6H, C H 3 ), 7.92 (d, 2H, J = 10 Hz, = C H
-), 9.23 (d, 2H, J = 10Hz, -N H -) [ppm] Elemental analysis: C 37.18, H 3.31, N 9.73 [%] Same calculated value (as C 9 F 6 H 10 N 2 S) :C 36.99,H
3.45, N 9.59 [%] Mass: m/e, 292 (m + ), 293 (m + +1); calculated value 292 (m) On the other hand, component B becomes colorless needle-like crystals by recrystallizing from toluene. It was N-(2-trifluoromethyl)-propenylthiourea (). CH 3 C (CF 3 ) = CH-NH-CS-NH 2 () Mp: 140-1℃ (dec.) IRmax (KBr disk): 3520, 3385, 3220, 3190,
3100, 1698, 1612, 1555, 1360, 1340, 1297,
1240, 1152, 1110, 910, 800, 750, 696, 667,
600 [cm -1 ] 1 H-NMR (Acetone-d 6 , TMS): δ 1.82 (S,
3H, CH 3 ), 7.90 (d, 1H, J = 10Hz, = CH -
NH-), 7.38 (bs, 2H, -NH 2 ), 8.98 (d, 1H,
J=10Hz, CH- NH- ) [ppm] Elemental analysis: C 32.98, H 3.69, N 15.36 [%] Same calculated value [as C 5 F 3 H 7 N 2 S]: C 32.61, H
3.83, N 15,21 [%] Mass: m/e, 184 (m + ); calculated value 184 (m) In addition, component C becomes yellow crystals by dissolving in ether and crystallizing with hexane, N,
It was N'-bis[(1-thiourido-2-trifluoromethyl)-propyl]thiourea (). Mp: 120−40 [℃] (dec) IRmax (KBrdisk): 3300, 3200, 1610, 1515,
1415, 1350, 1260, 1180, 1150, 1120, 795, 745
[cm -1 ] 1 H-NMR (Acetone-d 6 , TMS): 1.27 (d,
6H, J=7Hz, CH3 ), 2.9−3.7 (broad m,
2H,

【式】)、6.32(bq,2H,J= 8Hz,[Formula]), 6.32 (bq, 2H, J= 8Hz,

【式】)、7.28(broad S, 4H−NH2)、7.28(bd,4H,J=8Hz,
[Formula]), 7.28 (broad S, 4H−NH 2 ), 7.28 (bd, 4H, J=8Hz,

【式】)〔ppm〕 元素分析:C 30.96、H 4.58、N 19.00〔%〕 同計算値(C11F6H18N6S3として):C 29.73、
H 4.08、N 18.91〔%〕 Nass:m/e、fragment 308(m+−tiourea−
[Formula]) [ppm] Elemental analysis: C 30.96, H 4.58, N 19.00 [%] Same calculated value (as C 11 F 6 H 18 N 6 S 3 ): C 29.73,
H 4.08, N 18.91 [%] Nass: m/e, fragment 308 (m + −tiourea−

【式】)、292(m+−2tiourea)、223(292− CH3);計算値444(m) 実施例 2 チオ尿素3.8g(0.05mol)をジオキサン50mlに
溶解しトリフルオロメチルプロパナール12.6g
(0.1mol)を加えて室温に40時間攪拌し、次いで
硫酸マグネシウム12gを加えて20時間還流させ
た。反応溶液のTLCによる分析では成分Aおよ
び成分Bが主に生成していることが確かめられ
た。反応後不溶解分をろ別し、減圧下に濃縮後、
クロロホルム5mlから再結晶し成分B主体の部分
1.5gを得た。 ろ液を濃縮し、得られた褐色粘稠液7.6gをシ
リカゲル−クロロホルム−酢酸エチル系でクロマ
トグラフイーを行い成分A1.7gおよび成分B1.1
gに分けた。成分Bは上述のクロロホルムよりの
再結晶物と合わせトルエンより再結晶することに
よりほゞ無色の結晶として得られ、諸物性の測定
によりチオ尿素縮合体()と全く同一物である
ことを確認した。 また成分Aはトルエンより再結晶することによ
り、ほゞ無色の結晶となり諸物性の測定によりチ
オ尿素縮合体()と全く同一物質であることを
確認した。
[Formula]), 292 (m + -2tiourea), 223 (292- CH 3 ); Calculated value 444 (m) Example 2 Thiourea 3.8g (0.05mol) was dissolved in dioxane 50ml and trifluoromethylpropanal 12.6 g
(0.1 mol) and stirred at room temperature for 40 hours, then 12 g of magnesium sulfate was added and refluxed for 20 hours. Analysis of the reaction solution by TLC confirmed that component A and component B were mainly produced. After the reaction, undissolved matter was filtered out and concentrated under reduced pressure.
Recrystallized from 5 ml of chloroform and mainly contains component B.
1.5g was obtained. The filtrate was concentrated, and 7.6 g of the resulting brown viscous liquid was chromatographed using a silica gel-chloroform-ethyl acetate system to obtain 1.7 g of component A and 1.1 g of component B.
Divided into g. Component B was obtained as almost colorless crystals by combining with the above-mentioned recrystallized product from chloroform and recrystallizing from toluene, and it was confirmed by measurement of various physical properties that it was exactly the same as the thiourea condensate (). . Component A was recrystallized from toluene to form almost colorless crystals, and measurements of various physical properties confirmed that it was exactly the same substance as the thiourea condensate ().

Claims (1)

【特許請求の範囲】 1 一般式【式】 で表わされるチオ尿素誘導体。但しこの式におい
て、R1−はCH3C(CF3)=CH−またはCH3CH
(CF3)−CH(NH−CS−NH2)−を表し、R2−は
H−、CH3C(CF3)=CH−またはCH3CH(CF3
−CH(NH−CS−NH2)−を表わす。 2 化学式〔CH3C(CF3)=CH−NH〕−2C=Sで
表わされる第1項記載のチオ尿素誘導体。 3 化学式CH3C(CF3)=CH−NH−CS−NH2
で表わされる第1項記載のチオ尿素誘導体。 4 化学式〔CH3CH(CF3)−CH(NH−CS−
NH2)−NH〕−2C=Sで表わされる第1項記載の
チオ尿素誘導体。 5 チオ尿素とトリフルオロメチルプロパナール
とを反応させることを特徴とする一般式 R1
NH−CS−NH−R2(ここに、R1−はCH3C(CF3
=CH−またはCH3CH(CF3)−CH(NH−CS−
CH2)−を表わし、R2−はH−、CH3C(CF3)=
CH−またはCH3CH(CF3)−CH(NH−CS−
NH2)−を表わす。)で表わされる化合物の製法。
[Claims] 1. A thiourea derivative represented by the general formula [Formula]. However, in this formula, R 1 - is CH 3 C (CF 3 ) = CH- or CH 3 CH
( CF3 )-CH(NH-CS- NH2 )-, R2- is H-, CH3C ( CF3 )=CH- or CH3CH ( CF3 )
-CH(NH-CS- NH2 )-. 2. The thiourea derivative according to item 1, which is represented by the chemical formula [ CH3C ( CF3 )=CH-NH] -2C =S. 3 Chemical formula CH3C ( CF3 )=CH-NH-CS- NH2
The thiourea derivative according to item 1, which is represented by: 4 Chemical formula [CH 3 CH (CF 3 )-CH (NH-CS-
2. The thiourea derivative according to item 1, which is represented by NH2 )-NH] -2C =S. 5 General formula R 1 − characterized by reacting thiourea and trifluoromethylpropanal
NH−CS−NH−R 2 (here, R 1 − is CH 3 C (CF 3 )
=CH- or CH3CH ( CF3 )-CH(NH-CS-
CH 2 )−, R 2 − is H−, CH 3 C(CF 3 )=
CH− or CH 3 CH(CF 3 )−CH(NH−CS−
NH 2 )−. ) The method for producing the compound represented by
JP13184882A 1982-07-28 1982-07-28 Fluorine-containing thiourea derivative and its preparation Granted JPS5921663A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13184882A JPS5921663A (en) 1982-07-28 1982-07-28 Fluorine-containing thiourea derivative and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13184882A JPS5921663A (en) 1982-07-28 1982-07-28 Fluorine-containing thiourea derivative and its preparation

Publications (2)

Publication Number Publication Date
JPS5921663A JPS5921663A (en) 1984-02-03
JPH03382B2 true JPH03382B2 (en) 1991-01-07

Family

ID=15067520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13184882A Granted JPS5921663A (en) 1982-07-28 1982-07-28 Fluorine-containing thiourea derivative and its preparation

Country Status (1)

Country Link
JP (1) JPS5921663A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2647112A1 (en) * 1989-05-22 1990-11-23 Atochem NITROGEN POLYFLUORALKYL COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATIONS

Also Published As

Publication number Publication date
JPS5921663A (en) 1984-02-03

Similar Documents

Publication Publication Date Title
SU648087A3 (en) Method of obtaining sulfone
Buu-Hoï et al. NN′-Diarylthioureas and related compounds of potential biological interest
JPH03382B2 (en)
US2574505A (en) Process of preparing 2, 2-diphenyl-3-methyl-4-dimethylamino butyronitrile
US2827489A (en) Process for the preparation of 2-diphenylacetyl-1, 3-indandione
US3226379A (en) Novel 1,3-bis(polyhydroxyalkyl)-2-imidazolidinones and 1,3-bis(polyhydroxyalkyl)-imidazolidine-2-thiones
SU396326A1 (en) METHOD OF OBTAINING M-SULPHENYL SUBSTITUTED CARBAMINIC ACID ESTERS
SU415876A3 (en) METHOD FOR PRODUCING DERIVATIVES OF BENZIMIDAZOLE
JP3066594B2 (en) Aniline derivative and method for producing the same
JPS6360969A (en) Production of imidazole derivative
JPS59190974A (en) Production of 5-carbamoyl-6-methyl-4-substituted-1,2,3,4- tetrahydro-2-thioxopyrimidine
KR820000786B1 (en) Process for preparing uracil derivatives
JPS636063B2 (en)
US3053890A (en) Reaction products of formaldehyde and o-mercaptomethylbenzoic acid
JPH08176134A (en) New synthetic method of phthalide derivative
JP2671401B2 (en) .ALPHA.-Aminothioacetamide derivative and its production method
SU280353A1 (en) METHOD OF OBTAINING OXIMCARBAMATES
SU449045A1 (en) The method of obtaining dinaphthyl-3,3-thiodipropionate
EP0244810A1 (en) Process for producing 2-oxazolidinones
JPH0674250B2 (en) Method for producing thiocarbamate derivative
JPS6030319B2 (en) Method for producing 1,3-bis(tetrahydro-2-furanyl)uracil or its derivatives
JPH03258768A (en) Preparation of 1,3,5-perhydrotriazine-2,4,6-trithione derivative
JPH0379345B2 (en)
JPH07157465A (en) Production of n-substituted-1-methylthio-2-nitroetheneamines
JPS5817751B2 (en) Method for producing isoxazole derivatives